Cyclacel Pharmaceuticals, Inc. - Common Stock (CYCC)
0.2445
-0.0137 (-5.31%)
NASDAQ · Last Trade: May 1st, 5:28 PM EDT
Which stocks have an unusual volume on Wednesday?
Via Chartmill · April 30, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · April 30, 2025
Via Benzinga · April 30, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · April 29, 2025
Via Benzinga · April 29, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via Chartmill · April 29, 2025
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 29, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · April 29, 2025
Via Benzinga · April 29, 2025
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · April 28, 2025
Via Benzinga · April 28, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025

Via Benzinga · January 28, 2025

Via Benzinga · January 3, 2025

Cyclacel Pharmaceuticals shares are trading higher by 77% during Friday's session. The company announced a securities purchase agreement with investor David Lazar.
Via Benzinga · January 3, 2025

Via Benzinga · January 3, 2025

Via Benzinga · November 14, 2024

Via Benzinga · November 13, 2024

Via Benzinga · October 28, 2024

Via Benzinga · October 24, 2024

Via Benzinga · October 23, 2024

Via Benzinga · October 23, 2024

Via Benzinga · October 21, 2024